This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Seres Health Inc. (developing Ecobiotic therapeutics for various diseases by targeting the underlying biology of the microbiome) raised $10.6mm in its Series B round to returning shareholders Flagship Ventures and Enso Ventures, and first-time backers Mayo Clinic (which also concurrently entered into a drug discovery and development partnership with the company), Alexandria Venture Investments, and six private investors. Funds will support development of Seres' pipeline, which includes lead candidate SER109 (Phase I) for C. difficile.
Drug Discovery Tools
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?